Clinical Trials Logo

Graft-versus-host Disease (GVHD) clinical trials

View clinical trials related to Graft-versus-host Disease (GVHD).

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT05722912 Approved for marketing - Clinical trials for Graft-versus-host Disease (GVHD)

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Start date: n/a
Phase:
Study type: Expanded Access

To provide ruxolitinib through an expanded access to treat a single patient with cGVHD

NCT ID: NCT03147742 Approved for marketing - Clinical trials for Graft-versus-host Disease (GVHD)

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Start date: n/a
Phase:
Study type: Expanded Access

To provide ruxolitinib through an expanded access program for the treatment of graft-versus-host disease (GVHD) in United States to patients who are ineligible or unable to participate in any actively enrolling Incyte-sponsored clinical studies for ruxolitinib in the treatment of GVHD.